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１<Abstract>
Exploratory Study of Clinical, Histological, and Skin 
Microbiome Characteristics of Head and Neck Dermatitis 
in Adult Atopic Dermatitis
Hemin Lee
Department of Medicine
The Graduate School, Yonsei University
(Directed by Professor Kwang Hoon Lee)
Head and neck dermatitis (HND) is a unique subtype of atopic dermatitis (AD) 
which commonly manifests in late adolescence or adulthood. HND’s 
presentation of chronic eczematous lesions with diffuse erythema and itching or 
pruritus is often refractory to therapy and affects patient’s quality of life. 
However, HND is often underappreciated in clinics and detailed studies 
characterizing this specific AD subtype is very limited. 
This study sought to analyze the clinical and histological characteristics of HND 
patients. Further, as there are a growing number of AD studies focusing on the 
role of skin microbiome in the disease pathogenesis, microbiome analysis of 
HND patients in comparison to non-HND (N-HND) AD and normal (NL)
２subjects was performed. 
The results showed HND patients comprising approximately 2.4% of AD 
patients in an outpatient clinic setting. Compared to N-HND patients, HND 
initially presented with more severe disease status and elevated serum total IgE 
and serum specific IgE reactivity to Dermatophagoides farinae. Histologically, 
HND specimen showed thickened epidermis with increased vascular 
components and dermal inflammatory infiltrates. Although staining intensity 
did not differ between HND and NL specimen, the absolute number of staining 
intensity measurement was all higher in HND, supporting a contributory role of 
pro-inflammatory cytokines, chemokines, and neuroinflammatory factors in the 
HND pathogenesis. Lastly, the microbiome analysis of HND in comparison to 
N-HND AD and NL subjects showed no significant difference in the diversity 
of bacterial community. 
Combining findings from this study reaffirm that HND is a clinical subtype of 
AD that needs distinction from classical AD. In the future, further investigation 
of skin microbiome and inflammatory factors involved in vasculatures of AD 
facial regions will lead to development of potential therapeutic targets.  
Key words: head and neck dermatitis, red face syndrome, skin microbiome, 
atopic dermatitis 
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I. INTRODUCTION
Atopic dermatitis (AD) is a chronic, inflammatory skin disease affecting 1-3% 
of adults world-wide.1 Whereas classic AD seen during childhood mostly 
involves flexural areas of extremities, AD in elderly often show unique clinical 
features of head and neck dermatitis (HND), hand eczema, or nummular eczema 
regardless of presence of typical AD lesions.2 HND, which is also often referred 
to as “red face syndrome,” arises after adolescent years and encompasses a 
variety of clinical features involving scalp, face, and neck with eczematous, 
scaly patches to rosacea-like diffuse erythema.3-5 From experience, HND 
patients are generally refractory to therapy, and their quality of life is greatly 
affected by the presence of dermatosis.
４However, a detailed clinical characteristics, frequency, or pathogenesis 
underlying HND in AD is still not clear. Many studies emphasize patients’ 
hypersensitivity to Malassezia furfur, dust mite, and various environmental 
factors such as sweating, heat, and dryness.4 Moreover, a long-term use of 
topical steroid, or contact allergy to topical steroid is also suggested as a culprit 
in causing recalcitrant facial erythema.6
These erythematous changes are clearly evident in histological reviews as well, 
showing resemblance to rosacea and chronic eczema.7 Increased vasculature 
noted in HND is a possible contributory factor in provoking inflammation in 
these patients, leading to a vicious cycle. 
In more recent works, following advances in DNA sequencing, the focus of AD 
pathogenesis has shifted to analyzing microbial community.8 Even before the 
utilization of 16S rRNA for microbiome analysis, bacterial colonization by 
Staphylococcus aureus has long received attention in AD, with density of S. 
aureus colonization showing correlation to AD severity.9 It was hypothesized 
that the disrupted skin barrier often present in AD patients increases the number 
of skin colonization by microbes and eventually lead to subsequent IgE 
sensitization.10
Notable skin microbiome analysis in AD has been reported by Kong et al.,11
characterizing a reduction in overall microbial diversity in flares of childhood 
AD but a corresponding increase in Staphylococcus spp. But despite a number 
of microbiome studies in AD involving forearm or flexural areas, microbial
５community of other areas involved in AD has not yet been investigated. 
Commonly attempted treatment modalities for HND target the vessel 
components,12,13 or include anti-fungal medication to eradicate possible 
colonization with Malassezia.14 A trial of oral antibiotics minocycline, 
tetracycline have also been tried under a rationale to treat the disease similar to 
rosacea group. While these treatments show some improvement, none have 
been definitive, probably due to the heterogeneous nature of HND’s etiology. 
Therefore, gathering a need for a comprehensive study on HND to thoroughly 
understand its pathogenesis, the objective of this study was to describe HND’s 
clinical, histological, and microbial characteristics in comparison to control 
subjects. 
６II. MATERIALS AND METHODS
1. Patients
A. Patients for clinical analysis 
For clinical evaluation of HND patients, a database of approximately 5007 
AD patients who visited Yonsei University Severance Hospital’s 
Department of Dermatology was utilized. A query search of patients’ 
electronic medical records with keywords “redface syndrome” “red” 
“redface” – a synonym often used in clinic for HND—in both English and 
Korean were searched. 
B. Patients for histological analysis 
For histological evaluation of HND, histological database at Yonsei 
University Severance Hospital was utilized. A query search of AD patients 
who performed skin biopsy from face since year 2011 was performed, and 
3 patients were randomly selected from candidates of 9 patients. 
Histological analysis of NL face specimen was selected through a query 
search of patients who underwent skin biopsy since year 2013 on the face 
for suspected vitiligo or morphea. A crude age filtering of patients was 
performed to match AD patients’ age. Non-lesional specimens of these 
patients were chosen as NL face pathology. Among 10 candidates, 3 
７patients were randomly selected for image analysis. 
C. Patients for microbiome analysis 
For microbiome analysis of HND, 5 adult patients with AD based on 
Hanifin and Rajka criteria with striking redness on face were enrolled. 
Another 5 adult AD patients with typical AD lesions on flexural areas but 
no apparent HND were also enrolled as N-HND group. Finally, 5 NL 
subjects without AD were recruited. Considering a small sample number, 
the groups were enrolled age and sex matched. 
Peripheral blood samples and skin swab culture were obtained from 
enrolled patients as well as measurement of transepidermal water loss 
(TEWL) and objective measurement of redness with erythema index (EI). 
The major inclusion enrollment criterion was based on the following: no 
local or systemic treatment for at least 2 weeks prior to blood sampling, no 
significant infection or immune suppression, and no significant renal, 
hepatic, or other medical diseases. 
2. Laboratory examinations 
A. Laboratory evaluation for clinical analysis 
In a database of approximately 5007 patients available at Yonsei University 
Severance Hospital’s Department of Dermatology, laboratory evaluation 
from peripheral blood samples for total IgE and serum specific IgE (SIgE) 
８to D. farinae were available during their initial visit.
B. Laboratory evaluation for microbiome analysis patients 
In 15 patients who underwent skin swab for microbiome analysis, SIgE to 
D. farinae and Malassezia spp. were measured along with serum total IgE. 
3. Skin barrier determination 
In 15 patients who underwent skin swab for microbiome analysis, skin barrier 
function was determined by measurement of TEWL with tewameter 
(Courage+Khazaka, Köln, Germany). Objective measurement of redness with
EI was performed with Mexameter® (Courage+Khazaka). All values were 
measured three times per study subject. 
4. Immunohistochemistry and image analysis 
Immunohistochemical stains were performed using paraffin-embedded sections 
using antibodies against SDF1-α (1:100, ab25117, Abcam, Cambridge, United 
Kingdom), IL-1-β (1:100, ab2105, Abcam), TNF-α (1:50, ab1793, Abcam), 
TGF-β (1:100, ab66043, Abcam), and VR1(1:500, ab74855, Abcam). 
At 100x magnification, the longest distance from sub-corneal level to basal 
layer was chosen arbitrarily for epidermal thickness after calibrating the scale 
bar to pixels. Number of vessels/mm2 was counted in the dermis of each slide 
section within 100 µm distance from the epidermal-dermal junction. Staining 
９intensity was determined at 400x magnification at a randomly chosen area in 
the upper dermis with staining uptake under a constant staining intensity scale. 
The images were analyzed using MetaMorph Software (Molecular Devices, 
Downingtown, PA, USA). 
5. Skin microbiome analysis
A. Sampling and specimen processing 
Specimens from skin were obtained from erythematous lesions of cheek 
and forehead in HND patients. In N-HND AD patients, specimens were 
collected from acute eczematous lesions of face distinct from chronic 
lesions seen in HND patients. In normal patients, specimen was collected
from cheeks and forehead. Sampling was performed with skin swab of 
amies transport medium without charcoal. DNA was extracted from 
preparations using the DNeasy blood and tissue kit (Qiagen, Chatsworth, 
CA, USA) following the manufacturer’s protocol for genomic DNA 
isolation of Gram-positive bacteria. 
B. 16S rRNA PCR amplification and sequencing 
Two different primer sets were used for PCR, V2-4-8 and V3-6, 7-9 from 
the Ion 16STMMetagenomics Kit (Life Technologies, Carlsbad, CA, USA). 
Amplification products were purified and libraries were prepared using Ion 
Plus Fragment Library Kit (Life Technologies) and Ion Xpress™ Barcode 
１０
Adapters 1-16 Kit(Life Technologies) followed by template preparation 
using the Ion PGM Template OT2 400 Kit and the Ion OneTouch 2 System 
(Life Technologies). Sequencing was performed on an Ion Personal 
Genome Machine (PGM) System (Life Technologies), using the Ion PGM 
Sequencing 400 Kit with Ion 318 Chip v2. Bacterial identification was 
reported by the Ion Reporter (Life Technologies) using 2 databases, 
MicroSEQ(R) 16S Reference Library v2013.1 and Greengenes v13.5.
6. Statistical analysis 
The Student’s t-test for dependent samples or the nonparametric test of 
Wilcoxon was used for comparison of quantitative values between two groups. 
When comparing more than two groups, Kruskal-Wallis test was used. The 
condition of variables for normality was evaluated by Shapiro-Wilks test. The 
diversity of the microbial community was expressed as Simpson’s reciprocal 
index of diversity (1/D) and Shannon’s index. Differences in diversity data were 
analyzed using ANOVA with Tukey’s HSD post hoc test. Beta diversity was 
analyzed with principal coordinates analysis (PCoA) using the Yue-Clayton 
theta (θ) similarity coefficient. Quantitative data were described as median and 
range or as mean ± standard deviation. Statistical differences were considered to 
be significant if p < 0.05 using SAS (version 9.2, SAS Inc., Cary, NC, USA), 
and R package, version 3.1.2 1.2 (R Foundation for Statistical Computing, 
Vienna, Austria).
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III. RESULTS 
1. Clinical characteristics of HND patients visiting outpatient clinic 
In overall, there were 5007 AD patients who were enlisted in Yonsei University 
Severance Hospital’s Department of Dermatology AD database since year 2007. 
Among the 5007 patients, there were 120 patients (2.4%) with clinical records 
indicating a presence of HND. 120 HND and 4887 N-HND patients were age 
and sex matched with exact matching method. After eliminating all missing 
values in the database, a total of 74 HND and 74 N-HND patients were matched 
for comparison. There was no significant difference in the distribution of age 
and sex between HND and N-HND patients (age, p>0.9999, sex, p>0.9999). 
There was more percentage of extrinsic AD (total serum IgE higher than 200 
IU/mL or positive SIgE to D. farinae) patients in the HND group (p=0.0142). 
Also, HND patients presented with higher disease severity (p=0.0001), elevated 
total IgE (p<0.0001) at their initial clinic visit, and HND patients showed higher 
proportion of positive SIgE to D. farinae (p=0.0209). The onset age of AD in 
both groups was not different (p=0.7829). The comparison of HND with N-
HND patients is shown in Table 1. 
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Table 1. Comparison between HND and N-HND 
Characteristics HND N-HND p-value
No. subjects 74 74
Age, yrs (range) 24 (10-42) 24 (10-42) >0.9999
Sex >0.9999
Male, n (%) 48 (64.9) 48 (64.9)
Female, n (%) 26 (35.14) 26 (35.14)
Extrinsic AD, n (%) 71 (95.95) 62 (83.78) 0.0142
Onset of AD, yrs 0.7829
Birth~2 years, n (%) 15 (20.27) 12(16.22)
3-6 yrs 9(12.16) 13(17.57)
7-12 yrs 5(6.76) 9(12.16)
13-16 yrs 14(18.92) 13(17.57)
16-20 yrs 10 (13.52) 10 (13.51)
> 20 yrs 21(28.38) 17(22.97)
EASI, score (range) 22.45
(1.00-63.00)
12.90
(0.30-63.40)
0.0001
Total IgE, IU/mL (range) 4527.00
(28.00-5000.00)
766.00
(8.65-5000.00)
<0.0001
SIgE d2, n (%) 0.0209
0 2(2.70) 11(14.86)
1 3(4.05) 5(6.76)
2 7(9.46) 5(6.76)
3 8(10.81) 5(6.76)
4 4(5.41) 12(16.22)
5 12(16.22) 12(16.22)
6 38(51.35) 24(32.43)
5
Abbreviations: HND: head and neck dermatitis; N-HND: non-head and neck dermatitis, 
AD: atopic dermatitis; EASI, Eczema Area and Severity Index; SIgE: serum specific 
IgE, d2, D. farinae
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2. Histology of HND shows prominent epidermal change with 
presence of dense inflammatory cells and increased vasculature. 
To first investigate the general architecture of histological differences in HND 
to NL face histology, skin biopsy specimen were examined under hematoxylin 
and eosin (H&E) staining. In HND pathology, a general trend of hyperkeratosis, 
acanthosis, and parakeratosis was observed with dense inflammatory cells 
surrounding increased vasculatures (Figure 1A). When epidermal thickness was 
measured, the average epidermal thickness in HND group (0.5633 ± 0.04 mm) 
was significantly increased compared to NL group (0.17±0.06 mm). (p=0.0001, 
Figure 1B).
Increased vascularity in HND patients was additionally confirmed by 
immunohistochemical staining of factor VIII-related antigen (Figure 2A). 
Average vessel count for HND group was 15 ± 1.14 with concurrent average 
vessel area of 217.4 ± 20.63 µm2. On the other hand, average vessel count in 
normal face pathology was 4.50 ± 0.65 with average vessel area of 114.6 ± 
21.60 µm2. The difference in vessel count and average vessel size was 
statistically significant (p=0.0001, p=0.01 respectively, Figure 2B). 
１４
A)
B) 
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Figure 1. (A) Histological evaluation of face biopsy specimen in HND (left) 
show hyperkeratosis, acanthosis, and parakeratosis. Epidermal change is 
less prominent in NL face pathology (right). Also, dermis of HND shows 
prominent inflammatory cell infiltration with increased vessel components. 
(B) Average epidermal thickness of HND (0.5633 ± 0.04 mm) was increased 
compared to average epidermal thickness of NL control (0.17±0.06 mm). 
(p=0.0001).
１６
A)
B)
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Figure 2. (A) Immunohistochemistry for factor VIIIa-related antigen 
revealed increase in the number and size of vessels in the upper dermis of 
HND (left) compared to NL (right). Red arrows indicate endothelial cells of 
vessels in the dermis. Original magnification 100 x. (B) Average vessel 
count (15 ± 1.14) and average vessel area (217.4 ± 20.63 µm2) for HND was 
significantly increased compared to average vessel count (4.50 ± 0.65) and 
average vessel area (114.6 ± 21.60 µm2) of NL pathology (Vessel count, 
p=0.0001; vessel area, p=0.01).
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3. Immunohistochemical staining reveals increased uptake in HND, 
but the average staining intensity detected in HND and NL show
comparable results. 
Pathology of HND and NL face pathology were further compared with 
immunohistochemical staining for SDF1-α, IL-1β, TGF-β, TNF-α, and VR1. 
An absolute increased uptake in epidermis and dermis of HND was observed 
(Figure 3A, B). However, in image analysis of expression of relative staining 
intensity in the dermis showed no statistically significant difference between the 
two groups (Figure 4 A-E). 
１９
A)
２０
B)
Figure 3. Results of immunohistochemical stain at (A) original 
magnification x 200 and (B) original magnification x 400. 
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A)
B)
２２
C)
D)
２３
E)
Figure 4. Comparison of HND and NL pathology’s average intensity for 
immunochemistry staining in (A) SDF-1α, (B) IL-1 β, (C) TGF- β, (D) TNF-
α and (E) VR1. Although absolute values of staining intensity were all 
higher in HND, the only statistically significant difference was seen in (B) 
IL-1 β staining (p=0.008). 
２４
4. Baseline characteristics of patients undergoing skin swab for 
microbiome analysis  
Patients participating in skin microbiome analysis (5 HND, 5 N-HND AD, 5 NL) 
all performed measurement of TEWL to assess skin barrier function and EI to 
objectively record the degree of erythema. Moreover, baseline laboratory 
workups of serum total IgE, and SIgE to D. farinae and Malassezia spp. were 
performed. 
EI in HND, N-HND, and NL groups was 446.5 (294-521), 323 (274-383), and 
348 (236-396), respectively. A significant difference was noted in EI between 
the three groups (p=0.016), with markedly higher EI in the HND than in the N-
HND or NL group (p=0.008, p=0.021). There was no difference between EI of 
N-HND and NL group (p=0.440). 
TEWL between the three groups differed significantly as well (p<0.0001). 
There was no statistically significant difference between TEWL of N-HND and 
NL group (p=0.018), but TEWL in HND and N-HND group, HND and NL 
grouped proved to be significant (p<0.0001, p<0.0001, respectively). 
Difference in serum total IgE in three groups was noted (p<0.047), but 
comparison of each group in Mann-Whitney using Bonferroni correction 
showed no significant result. Summary of baseline characteristics are shown in 
Table 2. 
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Table 2. Comparison of EI, TEWL, Total IgE, and SIgE in patients 
undergoing microbiome analysis 
Characteristics HND N-HND NL p-value
Age, yrs (range) 31 (27-51) 26 (19-27) 31 (22-38) 0.08
Male, n (%) 2 (40) 4 (80) 4 (80) 0.33
EI, arbitrary unit (range) 446.5 
(294-521)
323   
(274-383)
348
(236-396)
0.016
TEWL, g/m2/h (range) 44.5 (30-74) 23 (16-31) 20 (9-28) <0.0001
Total IgE, IU/mL (range) 2529
(29.9-5000)
2815
(193-5000)
21.5
(8.52-397)
0.047
SIgE d2, n (%)* 3/3 (100%) 4/5 (80%) 0/2 (0%)
SIgE m70, n (%)* 3/5 (60%) 3/4 (75%) 0/0 (0%) 
Abbreviations : EI, erythema index; TEWL, transepidermal water loss; HND, head and 
neck dermatitis, N-HND, non-head and neck dermatitis, NL, normal, SIgE, serum 
specific IgE; d2, D. farinae; m70, Malassezia spp.
*SIgE result is shown in proportions of patients who showed reactivity and its 
percentage
２６
5. Species richness and diversity within skin microbiome samples of 
face 
Skin microbiome analysis was performed in 5 HND, 5 N-HND, and 5 NL 
patients. One sample of N-HND patient was discarded due to insufficient 
quantity of bacterial sample obtained in PCR quantification. 
After 16s rRNA gene deep sequencing, bacterial phyla consisting less than 1% 
of total reads mapped were excluded. The most commonly detected phyla were 
Firmicutes, Actinobacteria, Proteobacteria, and Bacteriodetes. A more detailed 
analysis was carried out at a family level, and a total of 16 families were 
detected. The mapped families and their proportions are shown in Figure 5.
Based on 16s rRNA gene deep sequencing data, alpha diversity was assessed by 
Simpson’s diversity index (1/D) and Shannon’s diversity index. There was no 
statistically significant difference between the HNL, N-HND, and NL group’s 
alpha diversity of the total microbiota (Simpson’s p=0.37, Shannon’s p=0.30,
Figure 6). 
Beta diversity analysis, which calculates the similarity between individuals, was 
performed with unweighted unifrac principal coordinates analysis (PCoA) and 
showed that each group shares similar microbiome communities (Figure 7). 
Lastly, when proportion of Staphylococcaceae family was compared, (HND: 
22.56%, N-HND: 27.69%, NL: 25.07%) the difference between the three 
groups was significant (p<0.001). 
２７
Figure 5. Comparison of skin microbiome in HND, N-HND, and NL 
patients. Diverse composition of microbiota is present at a family level. 
Abbreviations: N, Normal; R, head and neck dermatitis; NR, non-head and 
neck dermatitis 
２８
Figure 6. Simpson’s and Shannon’s alpha diversity index of the microbiota. 
Error bars represent 95% confidence interval of the mean. No statistically 
significant difference was seen between the groups. 
Abbreviations: NL: normal, HND: head and neck dermatitis, N-HND: non-
head and neck dermatitis 
２９
Figure 7. Unweighted unifract principal coordinate analysis (PCoA) plot of 
beta diversity. Plots 1~5 indicate normal (NL) group, plots 6~10 indicate 
head and neck dermatitis (HND), and plots 11~14 indicate non-head and 
neck dermatitis (N-HND). Percentage variation attributed to an axis is 
indicated as 39.81% for axis 1, and 22.24% for axis 2. 
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IV. DISCUSSION 
Even though a world-wide prevalence of AD has increased over the years, 
epidemiology and characteristics of AD in adult population have rarely been 
examined.15 The classic course of AD is onset of eczema in infancy to childhood 
years and subsiding of the disease before adolescence.16 However, adult-onset 
AD is not a rare presentation with reported prevalence around a range of 1-
3%.17 Among many patterns of clinical phenotypes present in adult AD patients, 
the most common presentation is recurrence of pre-existing eczema.3,18 But 
other distinct phenotypes of HND, nummular eczema, and hand eczema are also 
observed.5
HND is AD subtype that can be seen in patients without evident eczema history 
in childhood.19 However, this study’s analysis of onset age of AD in HND and 
N-HND revealed no apparent difference in the period of initial diagnosis of AD. 
Although there is a possible recall bias in this data considering a retrospective 
and survey nature of the data collection, more proportions of extrinsic AD 
patients and a higher number of patients with positive SIgE to D. farinae in 
HND group lead to an assumption that environmental and other extrinsic factors 
are more influential in the development of HND than genetic or inherent traits. 
In addition, higher disease severity score present in HND could manifest that 
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HND patients have eczema affecting other body sites as well or suffer from 
more refractory disease. 
A past study which overlooked histological features of adult AD patients with 
recalcitrant erythema on the face demonstrated a mixture of eczematous and 
steroid-induced rosacea-like changes.7 Not too different from an already 
published work, histological observation in this study showed epidermal change 
of hyperkeratosis, acanthosis, with parakeratosis, and a presence of increased 
vessels in HND lesions. Increase in the number and average area of vessels in 
the dermis, confirmed with factor VIII-related antigen, most probably lie behind 
the intense redness noted in HND patients. 
Immunohistochemical staining with proinflammatory cytokines and 
chemokines was additionally performed to confirm the presence of 
inflammatory mediators in AD lesions. As this study’s focus was on the redness 
of HND, the initial mark was set on vessel-related components. One major 
vascular component, VEGF, was already reported to be 25 times higher in AD 
lesional scale production compared to production in normal stratum corneum.20
But because VEGF can be up-regulated by other cytokines, this study aimed to 
check on the presence of other pro-inflammatory cytokines including TNF-α, 
TGF-β, and IL-1β, and chemokine SDF1-α. For one, TNF-α causes NF-κB 
activation as a transcription factor and regulate cell adhesion molecules (CAM),
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while IL-1 family contributes to dermal microvascular endothelial cells by up-
regulating intracellular adhesion molecule 1 (ICAM-1) or E-selectin 
expression.21 Chemokines also work in a cross-talk between endothelial cells 
and leukocytes involved in AD.21,22 Yet although the absolute values of staining 
intensity were all higher in immunohistochemistry work-up for HND group, 
there was no statistically significant difference in the two groups except IL-1β. 
Nevertheless, a plethora of pro-inflammatory mediators present in HND lesions 
might all act synergistically to contribute the expression of VEGF or other 
factors that ultimately lead to vessel dilatation and hyperpermeability, and 
future studies confirming their functional relevance will be necessary. 
One of notable immunohistochemical staining done in this study was staining of 
TRPV1 receptor, RV1. TRPV1 is a cation channel highly expressed in 
epidermal keratinocytes and nerve fibers of epidermis and dermis that is 
activated after stimulation with capsaicin, low pH or heat.23 Its role in rosacea, 
phenotypically similar in showing flush-like redness in face, has been gaining 
importance as TRPV1 opens a nonselective cation channel upon activation to 
increase intracellular calcium and mediate the release of neuropeptides like 
substance P and calcitonin gene-related peptide (CGRP). Since substance P 
possesses ability to mediate vasodilation and vascular permeability, it may 
parallel a release of mast cell and histamine, and increase in the cutaneous 
blood flow in both rosacea and AD.24 Application of TRPV1 antagonist, 
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capsazepine, was also reported to accelerate the recovery of barrier damage, 
indicating that the presence of TRPV1 might interfere with proper barrier 
function of our skin.25 Hence, increased presence of TRPV1 in HND of skin 
might indicate an important role of neuro-inflammation in the disease’s 
pathogenesis. In addition to laser modalities12,13 or antifungal agents14 used to 
target redness in HND patients, TRPV1 antagonists may prove to be another 
successful therapeutic target in the future.  
Lastly, exploration of skin microbiome in facial regions of HND, N-HND, and 
NL patients showed a plethora of bacterial species residing in all three groups. 
However, contrary to previous reports of more diverse bacterial community
present in normal, non-eczematous skin11, the diversity difference between 
HND, N-HND, and NL face in current study was not striking. Moreover, S. 
aureus was reported to be increased in atopic lesions when bacterial community 
was analyzed in typical flexural regions.11 But when bacterial community of 
face was performed at a family level, HND patients showed the lowest 
proportion of Staphylococcaceae.
Such results might occur from inconsistency of sampling or low number of 
species obtained. Also, bias in 16S studies due to varying DNA extraction and 
PCR amplification method needs to be considered in interpretation of results. 26
Seen from difficulty of detecting reads, including S. aureus, to species level by
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multiple probes used in this study, further validations on bacterial community of 
facial regions with eczema are warranted.
As culture-independent methods in researching skin microbiome will be more 
easily done in the future, efforts should be put into functional significance of 
differing bacterial diversity in disease status. Also, interplay between microbial 
community, genetics, and environment will yield even more clues into 
pathogenesis of AD and its various subtypes. 
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V. CONCLUSION 
This study comprehensively investigated clinical, histological, and microbial 
characteristics of HND developing in adult AD patients. In clinical aspects, 
HND patients—comprising around 2.4% of AD patients—possessed more 
extrinsic AD quality with elevated serum total IgE and positive SIgE to D.
farinae than N-HND patients. Histological overview of HND revealed features 
of chronic eczema as expected, along with increased vasculature qualities. 
Presence of inflammatory mediators in the epidermis and dermis should guide 
further studies investigating detailed interrelationships between various 
cytokines and chemokines. Also, neurovascular and neurogenic inflammation 
should be additionally studied as its importance is emphasized in phenotypically 
similar rosacea patients. Lastly, microbiome study showed no striking 
difference in diversity of the three groups. But with a more thorough study on 
various microbial communities, the role of minor bacterial communities and 
interplay between pathogenic and commensal bacteria in the onset of HND 
pathogenesis should not be overlooked. 
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ABSTRACT (IN KOREAN) 
안면부 침범 성인 아토피피부염 환자의 임상적, 조직학적 특성
및 피부 마이크로바이옴 관찰 연구
<지도교수 이광훈>
연세대학교 대학원 의학과
이혜민
아토피피부염의 여러 임상 아형 중 안면부와 두피, 목을 주로 침범하
는 피부염 (head and neck dermatitis, HND)은 일반적으로 청소년기
후반부나 성인기에 발현된다. 안면부의 뚜렷한 홍조가 동반된 이 만
성 습진성 병변은 가려움증이나 작열감을 동반하는 경우가 많고 통상
적인 아토피피부염의 치료에 잘 반응하지 않아 삶의 질에 큰 영향을
미친다. 그럼에도 불구하고 아직까지 HND 아형에 대해서는 많은 연
구가 이루어지지 않고 있다. 
그리하여 본 연구에서는 HND 환자들의 임상적, 조직학적 특성을 분
석하였다. 또한 최근 아토피피부염의 병인 연구에서 피부 마이크로바
이옴 분석을 이용한 연구들이 증가하는 추세에 따라 HND 환자들에
서도 안면부의 마이크로바이옴 분석을 안면부를 침범하지 않는 비-
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HND 환자들, 그리고 정상 피험자들과 비교하여 시행하였다. 
임상적인 분석 결과, 외래를 내원한 아토피피부염 환자의 2.4%가
HND 유형의 피부염을 보였으며 환자들은 비-HND 환자들에 비해 내
원 초기에 더 심각한 질병 상태와 증가되어 있는 혈청 총 IgE, 그리
고 집먼지 진드기에 대한 혈청 특이 IgE가 증가되어 있었다. 조직학
적 분석 결과, HND 표본에서 만성 습진 양상으로 변화된 표피와 표
피의 두께, 염증 세포의 침윤, 혈관의 숫자와 면적의 증가를 관찰하였
다. 이미지 분석 상 진피의 여러 cytokine, chemokine 등에 대한 염
색 강도의 차이는 보이지 않았지만, 절대적인 염색 강도는 HND 군이
더 높게 측정되었다.
또한 마이크로바이옴 분석을 통해 세 군간의 세균의 분포가 크게 다
르지 않음을 볼 수 있었으며 이는 안면부 마이크로바이옴의 특성일
수도 있으나 분석 방법의 바이어스나 마이크로바이옴 구성 균들간의
상호 작용 등의 가능성도 있어 향후에 더 연구하여 검증할 필요가 있
다고 생각한다.
이상의 결과로부터 이 연구에서는 아토피피부염의 한 아형인 HND
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임상적 특성, 조직학적 특성, 그리고 마이크로바이옴의 분포가 기존의
아토피피부염과 차이가 있음을 알 수 있었다. 이러한 안면부의 맥관
구조와 관련된 여러 염증인자, 마이크로바이옴의 결과들은 향후 난치
성인 HND 아토피피부염의 치료에 새로운 표적이 될 수 있을 것으로
생각한다. 
핵심되는 말: head and neck dermatitis (HND), 홍안 증후군, 마이크
로바이옴, 아토피피부염
